Cambridge Investment Research Advisors, Inc. Omeros Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,093 shares of OMER stock, worth $101,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,093
Previous 15,443
28.17%
Holding current value
$101,833
Previous $61,000
80.33%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding OMER
# of Institutions
142Shares Held
26.9MCall Options Held
959KPut Options Held
732K-
Black Rock Inc. New York, NY4.1MShares$37.7 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY4.01MShares$36.8 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$28.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.84MShares$16.9 Million0.01% of portfolio
-
Stifel Financial Corp St. Louis, MO1.58MShares$14.5 Million0.02% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $576M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...